EPAS1 and hepatocellular carcinoma: A recent study [127] utilized a multifunctional polyvinyl alcohol (PVA)/hyaluronic acid (HA)-based microsphere (PT/DOX-MS) loaded with doxorubicin and PT-2385, a potent HIF-2α inhibitor, to improve the treatment of HCC.